XORTX Therapeutics
XRTX
XORTX Therapeutics (XRTX) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.65
- EPS estimate
- −$0.84
- EPS surprise
- +22.20%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 17, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 17, 2025 | −$0.84 | −$0.65 | +22.20% | $0.00 | SEC |
| Q2 2025 | Aug 15, 2025 | −$1.25 | −$0.95 | +24.00% | $0.00 | SEC |
| Q1 2025 | May 16, 2025 | −$1.35 | −$0.95 | +29.63% | $0.00 | SEC |
| Q4 2024 | Mar 26, 2025 | −$1.45 | −$0.20 | +86.21% | $0.00 | SEC |
| Q3 2024 | Nov 15, 2024 | −$1.92 | −$1.45 | +24.31% | $0.00 | SEC |
| Q2 2024 | Aug 15, 2024 | −$2.51 | $0.30 | +111.98% | $0.00 | SEC |
| Q1 2024 | May 17, 2024 | −$2.24 | −$6.20 | −176.54% | $0.00 | SEC |
| Q4 2023 | Apr 4, 2024 | −$3.38 | $6.90 | +304.13% | $0.00 | SEC |
| Q3 2023 | Nov 16, 2023 | −$10.20 | −$3.35 | +67.17% | $0.00 | SEC |
| Q2 2023 | Aug 15, 2023 | −$7.79 | −$4.05 | +47.98% | $0.00 | SEC |
| Q1 2023 | May 16, 2023 | −$6.55 | −$4.95 | +24.44% | $0.00 | SEC |
| Q4 2022 | Apr 3, 2023 | −$10.89 | −$11.37 | −4.42% | $0.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$7.69 | −$6.23 | +19.02% | $0.00 | — |
| Q2 2022 | Aug 11, 2022 | −$6.34 | −$4.22 | +33.42% | $0.00 | — |
| Q1 2022 | May 16, 2022 | −$7.46 | −$6.25 | +16.29% | $0.00 | — |
| Q4 2021 | Apr 13, 2022 | −$4.26 | $33.97 | +896.51% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did XORTX Therapeutics (XRTX) last report earnings?
XORTX Therapeutics last reported on Nov 17, 2025, covering fiscal Q3 2025.
Did XRTX beat earnings estimates?
Yes. XORTX Therapeutics reported EPS of −$0.65 for Q3 2025 against a −$0.84 estimate — a 22.20% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.